Member Info for SocialistB

Part 1
Good afternoon everyone and thank you for your replies.

@MrChad, I am in full agreement with you, except I got the number to somewhere between 15-16 Billion shares in issue from today’s, 5 point something Billion shares. But that is just semantics, or maybe even worse, a miscalculation;-)

@Jerryspaniel, don’t you worry;-), I harbour no thoughts what so ever that GGP is on its way towards bankruptcy (although with higher dept, it automatically becomes a higher risk) And I have even less inclination to sell out in GGP.

GGP, under the leadership of Mr. Day is on the journey I have been arguing for, for years. Back in the early 2020, that did not seem to be the mainstream view or desire on this board.

Some may remember this link that I posted almost prolific back then:

https://stockhead.com.au/resources/this-is-how-3m-market-cap-minnow-ramelius-became-an-850m-gold-miner/

I am so pleased with the direction of GGP under the leadership of Mr. Day and what now seems to be the mainstream view on this board. WE ARE GOING MINING.

And it is always wonderful to attend the town hall meetings and meet follow investors who share this same desire.

And my feeling is many of us (you are excluded here, considering your holding:-) are just small fish, that have an ability to top on a monthly basis now a days.

So, with market psychology, most definitely playing a role in how we behave, I do think that the share price will have an effect on how high the mkt cap goes. (well obviously they are connected, they go hand in hand:-)

I just think that for smaller PI’s it really does matter whether we get 1 share or 3-5 shares per pound we invest on a regular basis, it has an effect on the cost per share and how much it has to rise before we recoup that expense.

In other words, for small PI’s we are more likely to be willing to keep continuously buying up from a consolidated price of 20 pence to 6o pence then we are from 80 pence to £2.40.

When we come up in that price region, then I think it is II’s that are going to take over, but how high are they willing to take it, assuming that they want to see a good return on their investment, here I am referring to dividends (which I know is a hot potato for you, as we have discussed that in the past), but that seemed to be one of possible several issues that cost Sandeep his job at Newcrest.


The magic number seems to be a consolidation of 10 from looking at the previous posts.

So that should bring the starting price after a consolidation up in the 70 pence region.

Over the next year, I believe our share price will be multiplied with an X factor, with all the news to come. Not least of first ore.

How many times it is going to be multiplied by, depends a lot on whether we get to buy Havieron outright or not.

At the Town Hall meeting Mr. Day said they we would need to consolidate the shares to reach the minimum criteria of 20 cent on ASX.

That criteria could be reached by just halving the number of shares in issue and leave us with shares in the region of 2.5 billion shares.

However, that number might float well in London, but is less likely to do so on the ASX and many other places in the world, accordingly to Mr. Day

Mr. Day suggested that a consolidation could happen with a number between 3 and 12.

He would take advice from the various brokers as to what the best price would be. Where the brokers see the biggest appetite, price wise.

Divided by either 12 or 3, that means we could end up in a scenario of some 420 million shares to 1.5 Billion shares in issue.

Or based on the current level of the share price. In a region of 21 pence to 84 pence.

The above numbers are just rough calculations. By no means are they exact, but it paints the picture well enough.

So, the question is: What is the magic number?

It’ does not matter how many shares are in issue, if the share price falls 10%, we lose 10% of the value of our investment.

But, I’ll argue that from a psychological point of view it matters a lot.

For me personally, when the share price falls from 7.7 pence to 7 pence, I have no care in the world.

But I know, I would not be able to say the same if the share price fell from 84 pence and down to 76 pence. That would really bother me, despite the fall being roughly around 10% in both cases.

Equally, psychologically the share price also has an effect on weather I want to buy or not.

I would not be equally keen to buy shares at 84 pence (consolidation by a factor of 12) compared to a share price of 21 pence (consolidation by a factor of 3).

And psychologically, I also think it is easier to triple the share price from a base of 21 pence compared with 84 pence when GGP hopefully strikes it big at Scallywag.

I am interested in hearing people’s thoughts.

What is your ideal number between 3 and 12 for consolidation and the resulting starting share price?

I am so looking forward to news on CBR.

Although it is not easily spread among humans, I'll still get a better night's sleep when we know CBR works.

(and of course it does)

A death rate above 50%, is no joke.

https://www.irishmirror.ie/news/irish-news/health-news/scientists-warn-caution-bird-flu-29350776.amp?fr=operanews

As far north as the appetite of the market allows.

And how far that is, well that is impossible to say as we simply do not know the markets appetite.

NO appetite what so ever and the share price will remain stagnant, hey it may even fall if there is an exodus of disappointed shareholders.

On the opposite end of the scale, if there all of a sudden is a wide interest from institutional Investors and other people who won't just flip the shares on a 30% profit, then I think that the share price could reach 10 to 20 pence.

And that is before we start talking about a positive announcement on CBR.

A patient at a hospital in Valencia might be infected with the Marburg virus.

This article claims it has a 88% mortality rate.

https://www.irishmirror.ie/lifestyle/travel/patient-isolated-hospital-after-deadly-29311841.amp?fr=operanews

We need a positive outcome from the CBR research taking place in the US, ASAP.

In tonight's local news here in London, shortly before 7 o'clock it was announced that the government have a goal of no new Hiv infections after 2030.

That to me sounds implausible, unless you can remove mankind's sex drive.

But, I do believe that there is a good chance that anyone infected by Hiv, can be cured by 2030.

And my favourite contender is much to everyone's surprise in this forum CBR:-)

Wonder if the UK government have heard about HEMOGENYX and their promising CBR technology?

@Pumpky, as long as you have no plans to leave your earthly shell behind anytime soon, I am sure you will experience 10 pence soon.

But when, now that is a good question.

It won't happen until the wider market gets an appetite for what HEMOGENYX has to offer.

When will that happen?

Good question, we should already be there in my view.

(Which, is obviously totally unbiased:-)

@JustHereForHemo and HerforHemo, fair point. If we are working with the US government and CBR proves a success, then there might be a different kind of funding coming our way.

Funding with very deep pockets and the ability fast track CBR.

And yes, that would indeed make the 4 million from New York look like pebbles.

@Gheko, don’t get me wrong. It would be nice to reach the same height as Novacyt around the 11-12 pound mark.
But is that even realistic?

There are for and against that question.

I do not think Novacyt breached the 1 Billion mark when they were at their highest, because they have less than 80 million shares in circulation.

Hemogenyx, on the other hand have over 1 Billion shares in circulation and a price in that region would but us at a market cap of over 13 Billion pounds.

So, unlikely to happen, from that point of view.

On the other hand, CBR reaches a much much larger market then Novacyt’s candidate would ever be able to, so when the market and the hoard discovers that, who knows what can happen?

Mr. Sandler have indicated we are likely to be worth Billions in the future.

If we get a successful CBR, I believe that to be true.

And surely, if CBR is as successful as we hope, then a meagre 2 Billion will not cut it.

So, does that rule out a share price north of 10 pounds, if you are patient enough?

Well that depends on a lot of things.

How much dilution do we have to go through to prove up CBR.

What kind of license deals can we get with our partners, as it does not seem like Hemogenyx is going it alone (and that can be a very smart move)

What is the profit margin going to be?

Will Hemogenyx be taken over by the US government under one of the military rules that allows the government to “forcefully” acquire a strategic and very important company?

There are many IF’s, but if they all work out in our favour and we are patient enough, I truly believe that we will be able to sell some of our shares in the pound category and not just in the pence category.

@HereForHemo, thanks for the summary.

It's the date of the 21-3-2023 that concerns me a bit.

My hope is that as soon as we get positive results (if we get positive results), who am I kidding, of course we do:-), we will see funding coming our way ASAP and that we won't have to wait until the 21-3-2023 simply because that date was decided upon at some point.

That approach would just lead to wasted days, and we can hardly afford that if we are in the beginning of what could become a new pandemic.

So, I am pleased that HEMOGENYX raised 4 million recently and stated among oter things it was to fasttrack CBR.

Getting a grant of an additional 4 million later on in March, will just be great and a stamp of approval.

With risk of being shot down here:
Mr. Sandler, please put CAR-T aside for now and focus on CBR.

The world might need it sooner, rather then later.

Unfortunately.

Marburg is no longer only confined to Equatorial Guinea but can now also be found in Cameroon.

https://amp.ibtimes.co.uk/first-ever-marburg-virus-disease-outbreak-confirmed-heres-what-we-know-so-far-1712887?fr=operanews

I say, that the world better wake up soon and progress CBR in a hurry.

If it is as good as we hope, and doesn't turn a patient into the elephant man 5 minutes after taking the medication then it most definitely should be out there right here right now.

So, we really need to ensure ASAP that the cure (CBR) is not worse than the disease.

Come on HEMO

@Chris, yes in the RNS released on the 9-1-2023 it states among other things the following:

“Single CBR Can Treat Multiple Viruses…… “

“Among them are Dengue, Ebola, MARBURG, Zika and Chikungunya. These viruses are among the most dangerous to humans, causing serious and often fatal diseases, and for which few effective treatment options exist………”

“The Directors believe that this significant discovery of a single target protein for use against multiple dangerous viruses is further evidence of the potential power of the Company's CBR technology,………”

https://www.lse.co.uk/rns/HEMO/single-cbr-can-treat-multiple-viruses-btbliw44cz9mry8.html

Those new ones, who have not read it yet, most definitely should.

It is my hope that we do not have to wait for funding in America to accelerate CBR.

It’s even more my hope that anyone considering supporting HEMOGENYX financially with a grant is not going to wait for a certain date in the future, just for the sake of it.

We have seen in the past how fast things and the world can get out of control and the financial impact it can have when there is a pandemic on the loose.

So, my hope, is that the world acts fast this time around.

And every day that is not done is a day wasted.

Let’s not wait until it is at our door step and just assume it is someone else’s problem.

In other words, my hope is that government’s and many charities of the world will hear about CBR and say, lets give this a shot.

And rather today, then tomorrow.

CBR might get fast tracked because of this.

https://www.dailystar.co.uk/news/world-news/new-killer-virus-fears-9-29216325.amp?fr=operanews

Question is just how many people will have to pay the ultimate price first, before the fasttracking begins.

In my view, we are already a day to late.

Covid showed us how fast things can get out of control, at least HEMOGENYX have a viable candidate in CBR.

The money that was just raised, can come to good use now.

When you have maxed out your ISA, you have indeed maxed out your ISA for that tax year.

@MrJinx

Yesterday you said: “I’m scoffing at the raise being labelled as a ‘stroke of genius’.”

I get you.

Believe me, it was not my first reaction either, Thursday morning.

But as I was pondering it over, I gradually began to see it that way.

When I, in my shocked state, was fuming for a bit Thursday morning, I was like, why more than a 160 million shares, why not just in the 20 - 21 million share range, so we would land on a big fat 1 Billion shares in issue? (I like round numbers and as I recall it, there is around 979 million shares in issue)

However, if Hemogenyx was to raise 4 million pounds on such a small number of shares, the share price would have to be in the 20 pence region.

For Hemogenyx’s share price to get that high, I assume, all the good news we are we are expecting would have had to be delivered.

Then again imagine that we get a 20-30% fall in the share price from the 20 pence range.

Now that would be a fall of proportions.

That would really, like really hurt a lot of us LTH’ers here.

And there would not be any more expected news, on the horizon in the foreseeable future, to drive up the share price.

That could leave to a further fall in the share price.

So again, something that would really hurt us LTH’ers, but not just us.

It would also hurt many who have bought in all the way up to 20 pence.

And this board would become a true cesspit, like nothing seen before, I am afraid.

So, rather take the fall in the share price at this level.

As far as we know, there has been no change to the science.

And we still have all the good news to look forward to.

2 added bonuses, it qualms concerns about raising cash, but most importantly, from now on and up until the next AGM no new investors have to fear a sudden 30% enlargement of the shares in issue, they know that it can only be enlarged with another 150 + million shares on the current mandate.

That is bound to give a calming effect.

So, in conclusion, I do end up thinking it was a stroke of genius.

What a shocker of a week – but here is a take on why it might not be so bad after all.

What happened on Thursday the 26-1-2023 was a total shock to me and I guess most of us.

I was, and am still, fully aware that Hemogenyx did not have, and still does not have, all the funds needed to progress, all our candidates through clinical trials.

So, it was obvious that Hemogenyx would have to get more money, somehow at some point.

But at no point, what so ever, had I considered, that money would be raised, at 2.5 Pence.

There is just no way, that I saw that one coming.

So, I was shocked.

I was counting on, that the soon to come IND and going clinical, would boost the share price.

I was hoping Hemogenyx would receive a grant to progress CBR, and that it would have a positive effect on the share price.

At this stage, I was expecting / hoping that Hemogenyx would be trading in the 10-15 pence region.

And it was at this point, I was anticipating Hemogenyx would raise some cash on the market.

So, to discover last Thursday, that Hemogenyx was raising £4 million at 2.5 pence, a price that is 4-6 times less than I expected, was truly a shock to the system.

But, when I had cooled down, I started to see the beauty in the manoeuvre.

1. It is not certain that Hemogenyx would be trading in the 10-15 pence region.

2. It is not certain that Hemogenyx will receive a grant to progress CBR.

3. It is not certain that a major pharmaceutical will bid on HEMO-CAR-T.

Now, I expect the 3 suggestions above to happen, but there is no guarantee.

Now, imagine 1 or all of the 3 scenarios above did not happen.

It could have a detrimental effect on the share price.

And as a no income business, it is only hope and expectations that can drive the share price up.

Because there are no fundamentals to do so.

And then there is no more expected good news around the corner.

So, for that reason, it was a smart move to raise money at 2.5 pence

All depending on when they decided to raise the money and started the process, the 2.5 Pence have either been at a premium or a discount.

But, that matters not.

What matters is that Hemogenyx now have about £4 million more in the coffer.

And we can still hope for all the positive news to materialize that we expect to happen in the near future.

If anything, Hemogenyx is now in a stronger position to drive various projects further forward.

So, while Thursdays RNS was a shocker, it was none the less also a stroke of genius.

Bring on February.

@Pumpky, I think it is fair to assume that both run 1 and 2 has been tested.

And been successful.

And then fair to assume run 3 will be as well.

Will a RNS land in a few minutes or during the week?

Either way, I think this week we end higher then last week.

It still beats how come FOMO Friday did not kick in last week.

This week, I am sure it will.

@HereforHemo
Your post at 0021 Tuesday 16-1-2023 was as WaitingRoom say's a perfect post.

What Mr. Sandler and his team has achieved on a shoestring of a budget is none less than absolutely fantastic.

And because of the Hemogenyx humanized mice, I dare believe it will be successful.

A column dedicated to JustHereForHemo and HereforHemo ought to have attracted many more replies in my opinion.

There are many, who over the years have delivered wonderful and insightful essays or comments on this board.

And the two of you have indeed been among those.

I would like to take this opportunity to thank you for the time and effort you have contributed and hope you will continue to do so.

It has been a delight to read most of them.

Thank you.

@Darwen

I am not trying to make any kind of prediction of what the share price will be in the next couple of weeks.

As I simply do not know, when the market will wake up or what appetite it has for the risk profile that is still associated with CBR as it is nowhere near clinical trials yet.

But you're right in assuming that if CBR really works, like in really really works, then I am most definitely of the opinion that HEMOGENYX can be traiding in pounds.

But that is likely to be years out in the future, unless we see a heard movement or a takeover attempt anytime soon.

And if there is ever an attempt on a take over, I beg of everyone:

DO NOT SELL CHEAPLY.

The potential here is massive.

And the hope is that the potential will manifest itself in solid science and safe medication and treatment.

And if that happens.

Wow.

You would not want to have sold your shares for pennies, or at least not too many of them.